Skip to main content
Fig. 3 | Malaria Journal

Fig. 3

From: Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes

Fig. 3

Screening for ivermectin metabolites effect on mosquito mortality. Anopheles stephensi mosquitoes were treated with blank human blood, blood containing ivermectin (IVM, 50 ng/mL), or ivermectin metabolite (M1-M9). Data represent three independent replicates per compound, each containing an average of 28 mosquitoes/condition. A Mortality over time. Mean mosquito survival was assessed after 24 h, 48 h and 72 h. Error bars correspond to the standard error or the mean. B Percent survivorship of An. stephensi 72 h; after feeding on ivermectin or its metabolites (M1–M9). Significant differences in the means of two groups are marked, *** shows a p-value < 0.001 with a t-test

Back to article page